방사선생물학

본문글자크기
  • [Int J Mol Sci] IGFL2-AS1, a Long Non-Coding RNA, Is Associated with Radioresistance in Colorectal Cancer

    KIRAMS / 이지용, 김다연, 김은주*

  • 출처
    Int J Mol Sci
  • 등재일
    2023 Jan 4
  • 저널이슈번호
    24(2):978. doi: 10.3390/ijms24020978.
  • 내용

    바로가기  >

    Abstract
    Precise prediction of radioresistance is an important factor in the treatment of colorectal cancer (CRC). To discover genes that regulate the radioresistance of CRCs, we analyzed an RNA sequencing dataset of patient-originated samples. Among various candidates, IGFL2-AS1, a long non-coding RNA (lncRNA), exhibited an expression pattern that was well correlated with radioresistance. IGFL2-AS1 is known to be highly expressed in various cancers and functions as a competing endogenous RNA. To further investigate the role of IGFL2-AS1 in radioresistance, which has not yet been studied, we assessed the amount of IGFL2-AS1 transcripts in CRC cell lines with varying degrees of radioresistance. This analysis showed that the more radioresistant the cell line, the higher the level of IGFL2-AS1 transcripts-a similar trend was observed in CRC samples. To directly assess the relationship between IGFL2-AS1 and radioresistance, we generated a CRC cell line stably expressing a small hairpin RNA (shRNA) targeting IGFL2-AS1. shRNA-mediated knockdown of IGFL2-AS1 decreased radioresistance and cell migration in vitro, establishing a functional role for IGFL2-AS1 in radioresistance. We also showed that downstream effectors of the AKT pathway played crucial roles. These data suggest that IGFL2-AS1 contributes to the acquisition of radioresistance by regulating the AKT pathway.

     

     

    Affiliations

    Jeeyong Lee 1, Da Yeon Kim 1 2, Younjoo Kim 3 4, Ui Sup Shin 3 5, Kwang Seok Kim 1 2, Eun Ju Kim 1 2
    1Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.
    2Department of Radiological and Medico-Oncological Sciences, University of Science and Technology, Daejeon 34113, Republic of Korea.
    3Department of Radiological and Clinical Research, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.
    4Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.
    5Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.

  • 키워드
    AKT; IGFL2-AS1; biomarker; long non-coding RNA; radioresistance
  • 편집위원

    본 연구는 대장암 환자 표본을 활용하여 대장암 방사선 치료 저항성의 핵심 인자로 long non-coding RNA인 IGFL2-AS1을 제시하였다. 저자들은 IGFL2-AS1의 선택적 저해를 통해 방사선저항성과 세포 migration이 감소하는 것을 확인하였으며, AKT 하위신호 조절을 통해 방사선저항성을 획득한다는 것을 검증하였다. 본 연구는 대장암의 방사선저항성 마커 발굴을 통해 방사선 치료 효율 예측과 기전을 제시했다는 점에 의의가 있다.

    2023-03-07 09:40:05

  • 덧글달기
    덧글달기
       IP : 18.191.223.123

    등록